Literature DB >> 8032696

Once more: prevention of nausea and emesis in cancer treatment.

M S Aapro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8032696     DOI： 10.1007/bf00417470

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  4 in total

1.  Who should receive a 5-HT3 antagonist?

Authors:  S B Kaye; D Khayat; M Aapro; V Diehl
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

2.  '... setron': are 5-HT3 receptor antagonists different?

Authors:  M S Aapro
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

Review 3.  Clinical studies to assess the economic impact of new therapies: pragmatic approaches to measuring costs.

Authors:  V Kirchner
Journal:  Anticancer Drugs       Date:  1993-12       Impact factor: 2.248

4.  Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience.

Authors:  B Sorbe
Journal:  Ann Oncol       Date:  1993       Impact factor: 32.976
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.